Selected research
Industry Growth & Trends
Global Biopharmaceuticals Contract Manufacturing Service Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Biopharmaceuticals Contract Manufacturing Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Biopharmaceuticals Contract Manufacturing Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Biopharmaceuticals Contract Manufacturing Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Biopharmaceuticals Contract Manufacturing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Biopharmaceuticals Contract Manufacturing Service market include WuXi Biologics, Takeda, Sanofi, Johnson & Johnson, Merck, Roche, Lonza Group, Pfizer and GlaxoSmithKline, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Biopharmaceuticals Contract Manufacturing Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Biopharmaceuticals Contract Manufacturing Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Biopharmaceuticals Contract Manufacturing Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Biopharmaceuticals Contract Manufacturing Service.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Biopharmaceuticals Contract Manufacturing Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Biopharmaceuticals Contract Manufacturing Service Market by Company
WuXi Biologics
Takeda
Sanofi
Johnson & Johnson
Merck
Roche
Lonza Group
Pfizer
GlaxoSmithKline
AbbVie
Samsung BioLogics
Rentschler Biotechnologie
ProBioGen
Novo Medi Sciences
JRS Pharma
Galentic Pharma
FUJIFILM Diosynth Biotechnologies
Boehringer Ingelheim
AGC Biologics
Biopharmaceuticals Contract Manufacturing Service Segment by Type
Packaging
Process Development
Manufacturing
Biopharmaceuticals Contract Manufacturing Service Segment by Application
Vaccines
Peptides and Protein
Biosimilars
Antibodies
Others
Biopharmaceuticals Contract Manufacturing Service Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biopharmaceuticals Contract Manufacturing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biopharmaceuticals Contract Manufacturing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biopharmaceuticals Contract Manufacturing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Biopharmaceuticals Contract Manufacturing Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Packaging
- Process Development
- Manufacturing
Applications
- Vaccines
- Peptides and Protein
- Biosimilars
- Antibodies
- Others
Companies covered
- WuXi Biologics
- Takeda
- Sanofi
- Johnson & Johnson
- Merck
- Roche
- Lonza Group
- Pfizer
- GlaxoSmithKline
- AbbVie
- Samsung BioLogics
- Rentschler Biotechnologie
- ProBioGen
- Novo Medi Sciences
- JRS Pharma
- Galentic Pharma
- FUJIFILM Diosynth Biotechnologies
- Boehringer Ingelheim
- AGC Biologics
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Biopharmaceuticals Contract Manufacturing Service Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Biopharmaceuticals Contract Manufacturing Service Market Size by Region (2021-2032)
- 1.4.1 Global Biopharmaceuticals Contract Manufacturing Service Market Size by Region (2021-2026)
- 1.4.2 Global Biopharmaceuticals Contract Manufacturing Service Market Size by Region (2027-2032)
- 1.5 Key Regions Biopharmaceuticals Contract Manufacturing Service Market Size (2021-2032)
- 1.5.1 North America Biopharmaceuticals Contract Manufacturing Service Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Biopharmaceuticals Contract Manufacturing Service Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Biopharmaceuticals Contract Manufacturing Service Market Size Growth Rate (2021-2032)
- 1.5.4 South America Biopharmaceuticals Contract Manufacturing Service Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Biopharmaceuticals Contract Manufacturing Service Market Size Growth Rate (2021-2032)
2 Biopharmaceuticals Contract Manufacturing Service Market by Type
- 2.1 Type Introduction
- 2.1.1 Packaging
- 2.1.2 Process Development
- 2.1.3 Manufacturing
- 2.2 Global Biopharmaceuticals Contract Manufacturing Service Market Size by Type
- 2.2.1 Global Biopharmaceuticals Contract Manufacturing Service Market Size Overview by Type (2021-2032)
- 2.2.2 Global Biopharmaceuticals Contract Manufacturing Service Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Biopharmaceuticals Contract Manufacturing Service Market Size Forecasted by Type (2027-2032)
- 2.3 Global Biopharmaceuticals Contract Manufacturing Service Market Size by Regions
- 2.3.1 North America Biopharmaceuticals Contract Manufacturing Service Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Biopharmaceuticals Contract Manufacturing Service Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Biopharmaceuticals Contract Manufacturing Service Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Biopharmaceuticals Contract Manufacturing Service Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Biopharmaceuticals Contract Manufacturing Service Market Size Breakdown by Type (2021-2026)
3 Biopharmaceuticals Contract Manufacturing Service Market by Application
- 3.1 Type Introduction
- 3.1.1 Vaccines
- 3.1.2 Peptides and Protein
- 3.1.3 Biosimilars
- 3.1.4 Antibodies
- 3.1.5 Others
- 3.2 Global Biopharmaceuticals Contract Manufacturing Service Market Size by Application
- 3.2.1 Global Biopharmaceuticals Contract Manufacturing Service Market Size Overview by Application (2021-2032)
- 3.2.2 Global Biopharmaceuticals Contract Manufacturing Service Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Biopharmaceuticals Contract Manufacturing Service Market Size Forecasted by Application (2027-2032)
- 3.3 Global Biopharmaceuticals Contract Manufacturing Service Market Size by Regions
- 3.3.1 North America Biopharmaceuticals Contract Manufacturing Service Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Biopharmaceuticals Contract Manufacturing Service Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Biopharmaceuticals Contract Manufacturing Service Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Biopharmaceuticals Contract Manufacturing Service Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Biopharmaceuticals Contract Manufacturing Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Biopharmaceuticals Contract Manufacturing Service Industry Trends
- 4.2 Biopharmaceuticals Contract Manufacturing Service Industry Drivers
- 4.3 Biopharmaceuticals Contract Manufacturing Service Industry Opportunities and Challenges
- 4.4 Biopharmaceuticals Contract Manufacturing Service Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Biopharmaceuticals Contract Manufacturing Service Revenue (2021-2026)
- 5.2 Global Biopharmaceuticals Contract Manufacturing Service Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Biopharmaceuticals Contract Manufacturing Service Key Company Headquarters & Area Served
- 5.4 Global Biopharmaceuticals Contract Manufacturing Service Company, Product Type & Application
- 5.5 Global Biopharmaceuticals Contract Manufacturing Service Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Biopharmaceuticals Contract Manufacturing Service Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Biopharmaceuticals Contract Manufacturing Service Players Market Share by Revenue in 2025
- 5.6.3 2025 Biopharmaceuticals Contract Manufacturing Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 WuXi Biologics
- 6.1.1 WuXi Biologics Company Information
- 6.1.2 WuXi Biologics Business Overview
- 6.1.3 WuXi Biologics Biopharmaceuticals Contract Manufacturing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 WuXi Biologics Biopharmaceuticals Contract Manufacturing Service Product Portfolio
- 6.1.5 WuXi Biologics Recent Developments
- 6.2 Takeda
- 6.2.1 Takeda Company Information
- 6.2.2 Takeda Business Overview
- 6.2.3 Takeda Biopharmaceuticals Contract Manufacturing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Takeda Biopharmaceuticals Contract Manufacturing Service Product Portfolio
- 6.2.5 Takeda Recent Developments
- 6.3 Sanofi
- 6.3.1 Sanofi Company Information
- 6.3.2 Sanofi Business Overview
- 6.3.3 Sanofi Biopharmaceuticals Contract Manufacturing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Sanofi Biopharmaceuticals Contract Manufacturing Service Product Portfolio
- 6.3.5 Sanofi Recent Developments
- 6.4 Johnson & Johnson
- 6.4.1 Johnson & Johnson Company Information
- 6.4.2 Johnson & Johnson Business Overview
- 6.4.3 Johnson & Johnson Biopharmaceuticals Contract Manufacturing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Johnson & Johnson Biopharmaceuticals Contract Manufacturing Service Product Portfolio
- 6.4.5 Johnson & Johnson Recent Developments
- 6.5 Merck
- 6.5.1 Merck Company Information
- 6.5.2 Merck Business Overview
- 6.5.3 Merck Biopharmaceuticals Contract Manufacturing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Merck Biopharmaceuticals Contract Manufacturing Service Product Portfolio
- 6.5.5 Merck Recent Developments
- 6.6 Roche
- 6.6.1 Roche Company Information
- 6.6.2 Roche Business Overview
- 6.6.3 Roche Biopharmaceuticals Contract Manufacturing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Roche Biopharmaceuticals Contract Manufacturing Service Product Portfolio
- 6.6.5 Roche Recent Developments
- 6.7 Lonza Group
- 6.7.1 Lonza Group Company Information
- 6.7.2 Lonza Group Business Overview
- 6.7.3 Lonza Group Biopharmaceuticals Contract Manufacturing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Lonza Group Biopharmaceuticals Contract Manufacturing Service Product Portfolio
- 6.7.5 Lonza Group Recent Developments
- 6.8 Pfizer
- 6.8.1 Pfizer Company Information
- 6.8.2 Pfizer Business Overview
- 6.8.3 Pfizer Biopharmaceuticals Contract Manufacturing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Pfizer Biopharmaceuticals Contract Manufacturing Service Product Portfolio
- 6.8.5 Pfizer Recent Developments
- 6.9 GlaxoSmithKline
- 6.9.1 GlaxoSmithKline Company Information
- 6.9.2 GlaxoSmithKline Business Overview
- 6.9.3 GlaxoSmithKline Biopharmaceuticals Contract Manufacturing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 GlaxoSmithKline Biopharmaceuticals Contract Manufacturing Service Product Portfolio
- 6.9.5 GlaxoSmithKline Recent Developments
- 6.10 AbbVie
- 6.10.1 AbbVie Company Information
- 6.10.2 AbbVie Business Overview
- 6.10.3 AbbVie Biopharmaceuticals Contract Manufacturing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 AbbVie Biopharmaceuticals Contract Manufacturing Service Product Portfolio
- 6.10.5 AbbVie Recent Developments
- 6.11 Samsung BioLogics
- 6.11.1 Samsung BioLogics Company Information
- 6.11.2 Samsung BioLogics Business Overview
- 6.11.3 Samsung BioLogics Biopharmaceuticals Contract Manufacturing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Samsung BioLogics Biopharmaceuticals Contract Manufacturing Service Product Portfolio
- 6.11.5 Samsung BioLogics Recent Developments
- 6.12 Rentschler Biotechnologie
- 6.12.1 Rentschler Biotechnologie Company Information
- 6.12.2 Rentschler Biotechnologie Business Overview
- 6.12.3 Rentschler Biotechnologie Biopharmaceuticals Contract Manufacturing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Rentschler Biotechnologie Biopharmaceuticals Contract Manufacturing Service Product Portfolio
- 6.12.5 Rentschler Biotechnologie Recent Developments
- 6.13 ProBioGen
- 6.13.1 ProBioGen Company Information
- 6.13.2 ProBioGen Business Overview
- 6.13.3 ProBioGen Biopharmaceuticals Contract Manufacturing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 ProBioGen Biopharmaceuticals Contract Manufacturing Service Product Portfolio
- 6.13.5 ProBioGen Recent Developments
- 6.14 Novo Medi Sciences
- 6.14.1 Novo Medi Sciences Company Information
- 6.14.2 Novo Medi Sciences Business Overview
- 6.14.3 Novo Medi Sciences Biopharmaceuticals Contract Manufacturing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Novo Medi Sciences Biopharmaceuticals Contract Manufacturing Service Product Portfolio
- 6.14.5 Novo Medi Sciences Recent Developments
- 6.15 JRS Pharma
- 6.15.1 JRS Pharma Company Information
- 6.15.2 JRS Pharma Business Overview
- 6.15.3 JRS Pharma Biopharmaceuticals Contract Manufacturing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 JRS Pharma Biopharmaceuticals Contract Manufacturing Service Product Portfolio
- 6.15.5 JRS Pharma Recent Developments
- 6.16 Galentic Pharma
- 6.16.1 Galentic Pharma Company Information
- 6.16.2 Galentic Pharma Business Overview
- 6.16.3 Galentic Pharma Biopharmaceuticals Contract Manufacturing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 Galentic Pharma Biopharmaceuticals Contract Manufacturing Service Product Portfolio
- 6.16.5 Galentic Pharma Recent Developments
- 6.17 FUJIFILM Diosynth Biotechnologies
- 6.17.1 FUJIFILM Diosynth Biotechnologies Company Information
- 6.17.2 FUJIFILM Diosynth Biotechnologies Business Overview
- 6.17.3 FUJIFILM Diosynth Biotechnologies Biopharmaceuticals Contract Manufacturing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 FUJIFILM Diosynth Biotechnologies Biopharmaceuticals Contract Manufacturing Service Product Portfolio
- 6.17.5 FUJIFILM Diosynth Biotechnologies Recent Developments
- 6.18 Boehringer Ingelheim
- 6.18.1 Boehringer Ingelheim Company Information
- 6.18.2 Boehringer Ingelheim Business Overview
- 6.18.3 Boehringer Ingelheim Biopharmaceuticals Contract Manufacturing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 Boehringer Ingelheim Biopharmaceuticals Contract Manufacturing Service Product Portfolio
- 6.18.5 Boehringer Ingelheim Recent Developments
- 6.19 AGC Biologics
- 6.19.1 AGC Biologics Company Information
- 6.19.2 AGC Biologics Business Overview
- 6.19.3 AGC Biologics Biopharmaceuticals Contract Manufacturing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.19.4 AGC Biologics Biopharmaceuticals Contract Manufacturing Service Product Portfolio
- 6.19.5 AGC Biologics Recent Developments
7 North America
- 7.1 North America Biopharmaceuticals Contract Manufacturing Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Biopharmaceuticals Contract Manufacturing Service Market Size by Country (2021-2026)
- 7.3 North America Biopharmaceuticals Contract Manufacturing Service Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Biopharmaceuticals Contract Manufacturing Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Biopharmaceuticals Contract Manufacturing Service Market Size by Country (2021-2026)
- 8.3 Europe Biopharmaceuticals Contract Manufacturing Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Biopharmaceuticals Contract Manufacturing Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Biopharmaceuticals Contract Manufacturing Service Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Biopharmaceuticals Contract Manufacturing Service Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Biopharmaceuticals Contract Manufacturing Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Biopharmaceuticals Contract Manufacturing Service Market Size by Country (2021-2026)
- 10.3 South America Biopharmaceuticals Contract Manufacturing Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Biopharmaceuticals Contract Manufacturing Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Biopharmaceuticals Contract Manufacturing Service Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Biopharmaceuticals Contract Manufacturing Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst